G. Andre Turenne's most recent trade in Voyager Therapeutics Inc was a trade of 80,000 Common Stock done . Disclosure was reported to the exchange on March 19, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | G. Andre Turenne | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 80,000 | 322,375 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | G. Andre Turenne | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 189,000 | 189,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | G. Andre Turenne | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 94,000 | 242,375 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | G. Andre Turenne | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 7.55 per share. | 11 Feb 2021 | 7,977 | 148,375 (0%) | 0% | 7.5 | 60,226 | Common Stock |
| Voyager Therapeutics Inc | G. Andre Turenne | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 8.62 per share. | 12 Jan 2021 | 10,443 | 156,352 (0%) | 0% | 8.6 | 90,019 | Common Stock |